
PubMed:1823158
Annnotations
Glycan-Motif
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 305-308 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T2 | 305-308 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T3 | 388-391 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T4 | 388-391 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T5 | 846-849 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T6 | 846-849 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T7 | 1359-1362 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T8 | 1359-1362 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 305-308 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T3 | 388-391 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T5 | 846-849 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T7 | 1359-1362 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 305-308 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T2 | 305-308 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T3 | 388-391 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T4 | 388-391 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T5 | 846-849 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T6 | 846-849 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T7 | 1359-1362 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T8 | 1359-1362 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
TextSentencer_T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
TextSentencer_T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
TextSentencer_T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
TextSentencer_T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
TextSentencer_T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
TextSentencer_T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
TextSentencer_T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
TextSentencer_T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
TextSentencer_T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
TextSentencer_T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 305-308 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T2 | 388-391 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T3 | 846-849 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T4 | 1359-1362 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
GlycoBiology-FMA
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
_T1 | 40-51 | FMAID:63840 | denotes | cell nuclei |
_T2 | 40-51 | FMAID:162303 | denotes | cell nuclei |
_T3 | 68-75 | FMAID:166048 | denotes | neurite |
_T4 | 68-75 | FMAID:61814 | denotes | neurite |
_T5 | 293-304 | FMAID:196811 | denotes | ganglioside |
_T6 | 293-304 | FMAID:82816 | denotes | ganglioside |
_T7 | 392-402 | FMAID:167230 | denotes | into cells |
_T8 | 397-402 | FMAID:169002 | denotes | cells |
_T9 | 397-402 | FMAID:68646 | denotes | cells |
_T10 | 415-424 | FMAID:165656 | denotes | compounds |
_T11 | 415-424 | FMAID:67745 | denotes | compounds |
_T12 | 738-744 | FMAID:162307 | denotes | plasma |
_T13 | 738-753 | FMAID:66843 | denotes | plasma membrane |
_T14 | 738-753 | FMAID:63841 | denotes | plasma membrane |
_T15 | 738-753 | FMAID:164993 | denotes | plasma membrane |
_T16 | 738-753 | FMAID:210691 | denotes | plasma membrane |
_T17 | 738-753 | FMAID:162306 | denotes | plasma membrane |
_T18 | 738-753 | FMAID:166047 | denotes | plasma membrane |
_T19 | 1011-1016 | FMAID:217859 | denotes | rates |
_T20 | 1025-1028 | FMAID:182506 | denotes | Ca2 |
_T21 | 1025-1028 | FMAID:272658 | denotes | Ca2 |
_T22 | 1025-1028 | FMAID:272430 | denotes | Ca2 |
_T23 | 1091-1094 | FMAID:182506 | denotes | Ca2 |
_T24 | 1091-1094 | FMAID:272430 | denotes | Ca2 |
_T25 | 1091-1094 | FMAID:272658 | denotes | Ca2 |
_T26 | 1282-1285 | FMAID:182506 | denotes | Ca2 |
_T27 | 1282-1285 | FMAID:272658 | denotes | Ca2 |
_T28 | 1282-1285 | FMAID:272430 | denotes | Ca2 |
_T29 | 1287-1290 | FMAID:165234 | denotes | CaM |
_T30 | 1378-1381 | FMAID:272658 | denotes | Ca2 |
_T31 | 1378-1381 | FMAID:272430 | denotes | Ca2 |
_T32 | 1378-1381 | FMAID:182506 | denotes | Ca2 |
_T33 | 1391-1394 | FMAID:182506 | denotes | Ca2 |
_T34 | 1391-1394 | FMAID:272430 | denotes | Ca2 |
_T35 | 1391-1394 | FMAID:272658 | denotes | Ca2 |
_T36 | 1396-1399 | FMAID:165234 | denotes | CaM |
uniprot-human
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 213-215 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T2 | 286-288 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T3 | 381-383 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T4 | 439-441 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T5 | 531-533 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T6 | 694-696 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T7 | 863-865 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T8 | 989-991 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T9 | 1192-1194 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T10 | 1352-1354 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
T11 | 1499-1501 | http://www.uniprot.org/uniprot/Q96PL6 | denotes | SC |
uniprot-mouse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1025-1028 | http://www.uniprot.org/uniprot/P00920 | denotes | Ca2 |
T2 | 1091-1094 | http://www.uniprot.org/uniprot/P00920 | denotes | Ca2 |
T3 | 1282-1285 | http://www.uniprot.org/uniprot/P00920 | denotes | Ca2 |
T4 | 1378-1381 | http://www.uniprot.org/uniprot/P00920 | denotes | Ca2 |
T5 | 1391-1394 | http://www.uniprot.org/uniprot/P00920 | denotes | Ca2 |
GlycoBiology-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 139-149 | http://purl.bioontology.org/ontology/NCBITAXON/127244 | denotes | mechanisms |
T2 | 397-402 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-6 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | Sialyl |
T2 | 193-199 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | sialyl |
T3 | 68-85 | http://purl.obolibrary.org/obo/GO_0031175 | denotes | neurite outgrowth |
T4 | 450-458 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degraded |
T5 | 603-617 | http://purl.obolibrary.org/obo/GO_0001775 | denotes | activity. Cell |
T6 | 701-710 | http://purl.obolibrary.org/obo/GO_0051179 | denotes | localized |
T7 | 1489-1498 | http://purl.obolibrary.org/obo/GO_0051179 | denotes | localized |
T8 | 701-725 | http://purl.obolibrary.org/obo/GO_0051647 | denotes | localized in the nucleus |
T9 | 894-907 | http://purl.obolibrary.org/obo/GO_0032774 | denotes | RNA synthesis |
T10 | 898-907 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
T11 | 974-987 | http://purl.obolibrary.org/obo/GO_0006351 | denotes | transcription |
GO-CC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 40-44 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T2 | 111-115 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T3 | 242-246 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T4 | 397-402 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T5 | 613-617 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | Cell |
T6 | 68-75 | http://purl.obolibrary.org/obo/GO_0043005 | denotes | neurite |
T7 | 459-462 | http://purl.obolibrary.org/obo/GO_0005731 | denotes | nor |
T8 | 718-725 | http://purl.obolibrary.org/obo/GO_0005634 | denotes | nucleus |
T9 | 738-753 | http://purl.obolibrary.org/obo/GO_0005886 | denotes | plasma membrane |
T10 | 745-753 | http://purl.obolibrary.org/obo/GO_0016020 | denotes | membrane |
T11 | 1062-1075 | http://purl.obolibrary.org/obo/GO_0005622 | denotes | intracellular |
EDAM-topics
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 59-67 | http://edamontology.org/topic_1312 | denotes | promotes |
T2 | 59-67 | http://edamontology.org/topic_0111 | denotes | promotes |
T3 | 59-67 | http://edamontology.org/topic_0749 | denotes | promotes |
T4 | 553-564 | http://edamontology.org/topic_0154 | denotes | metabolites |
T5 | 553-564 | http://edamontology.org/topic_0079 | denotes | metabolites |
T6 | 718-725 | http://edamontology.org/topic_0616 | denotes | nucleus |
T7 | 974-987 | http://edamontology.org/topic_0110 | denotes | transcription |
T8 | 974-987 | http://edamontology.org/topic_3512 | denotes | transcription |
T9 | 974-987 | http://edamontology.org/topic_0203 | denotes | transcription |
T10 | 974-987 | http://edamontology.org/topic_3308 | denotes | transcription |
GlycoBiology-Epitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
PD-GlycoEpitope-B_T1 | 305-308 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
PD-GlycoEpitope-B_T2 | 388-391 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
PD-GlycoEpitope-B_T3 | 846-849 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
PD-GlycoEpitope-B_T4 | 1359-1362 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 97-110 | Disease | denotes | neuroblastoma | http://purl.obolibrary.org/obo/MONDO_0005072 |
T2 | 228-241 | Disease | denotes | neuroblastoma | http://purl.obolibrary.org/obo/MONDO_0005072 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 97-110 | Phenotype | denotes | neuroblastoma | HP:0003006 |
T2 | 228-241 | Phenotype | denotes | neuroblastoma | HP:0003006 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 305-308 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T2 | 388-391 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T3 | 846-849 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 1359-1362 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 305-308 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T2 | 388-391 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T3 | 846-849 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T4 | 1359-1362 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 97-110 | Phenotype | denotes | neuroblastoma | HP:0003006 |
T2 | 228-241 | Phenotype | denotes | neuroblastoma | HP:0003006 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 68-75 | Body_part | denotes | neurite | http://purl.obolibrary.org/obo/GO_0043005 |
T2 | 718-725 | Body_part | denotes | nucleus | http://purl.obolibrary.org/obo/GO_0005634|http://purl.obolibrary.org/obo/UBERON_0000125 |
T4 | 738-753 | Body_part | denotes | plasma membrane | http://purl.obolibrary.org/obo/GO_0005886 |
T5 | 1062-1075 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
TextSentencer_T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
TextSentencer_T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
TextSentencer_T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
TextSentencer_T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
TextSentencer_T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
TextSentencer_T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
TextSentencer_T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
TextSentencer_T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
TextSentencer_T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
TextSentencer_T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
TextSentencer_T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-121 | Sentence | denotes | Sialyl cholesterol is translocated into cell nuclei and it promotes neurite outgrowth in a mouse neuroblastoma cell line. |
T2 | 122-347 | Sentence | denotes | To determine the mechanisms of the neuritogenesis induced by synthetic sialyl cholesterol (SC) in a mouse neuroblastoma cell line, Neuro2a, the biochemical fate of SC and ganglioside GM1 (IV3NeuAc-GgOse4Cer) was investigated. |
T3 | 348-438 | Sentence | denotes | The kinetics of incorporation of SC and GM1 into cells for the two compounds were similar. |
T4 | 439-612 | Sentence | denotes | SC was not degraded nor modified for at least 24 h after the incorporation, indicating that SC itself and not its metabolites were responsible for the neuritogenic activity. |
T5 | 613-800 | Sentence | denotes | Cell fractionation experiments showed that approximately 40% of the incorporated SC was localized in the nucleus, 25% in the plasma membrane fractions, and 11-14% in the granule fraction. |
T6 | 801-850 | Sentence | denotes | This distribution was different from that of GM1. |
T7 | 851-988 | Sentence | denotes | The nuclear SC was found to affect de novo RNA synthesis, indicating its biological effect may be mediated at the level of transcription. |
T8 | 989-1115 | Sentence | denotes | SC also increased the rates of both Ca2+ influx and efflux, although the intracellular level of total Ca2+ remained unchanged. |
T9 | 1116-1299 | Sentence | denotes | Levels of inositol 1,4,5-triphosphate (IP3) also remained unchanged and the SC dependent neuritogenesis was not inhibited by an excess amount of W-7, an inhibitor of Ca2+/CaM kinases. |
T10 | 1300-1441 | Sentence | denotes | These results again accord with the suggestion that SC and GM1 do not utilize Ca2+, IP3 or Ca2+/CaM as a second messenger for neuritogenesis. |
T11 | 1442-1540 | Sentence | denotes | Rather it appears very likely that the nuclear localized SC may play a key role in neuritogenesis. |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 305-308 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T2 | 388-391 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T3 | 846-849 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T4 | 1359-1362 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 97-110 | Disease | denotes | neuroblastoma | MONDO:0005072 |
T2 | 228-241 | Disease | denotes | neuroblastoma | MONDO:0005072 |
GlyCosmos15-NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 91-96 | OrganismTaxon | denotes | mouse | 10088|10090 |
T3 | 222-227 | OrganismTaxon | denotes | mouse | 10088|10090 |
GlyCosmos15-FMA
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 68-75 | Body_part | denotes | neurite | FMA:61814 |
T2 | 738-753 | Body_part | denotes | plasma membrane | FMA:63841 |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 305-308 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T2 | 388-391 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T3 | 846-849 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 1359-1362 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
NCBITAXON
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
T1 | 91-96 | OrganismTaxon | denotes | mouse | 10088|10090 |
T3 | 222-227 | OrganismTaxon | denotes | mouse | 10088|10090 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 68-75 | Body_part | denotes | neurite | http://purl.obolibrary.org/obo/GO_0043005 |
T2 | 718-725 | Body_part | denotes | nucleus | http://purl.obolibrary.org/obo/GO_0005634|http://purl.obolibrary.org/obo/UBERON_0000125 |
T4 | 738-753 | Body_part | denotes | plasma membrane | http://purl.obolibrary.org/obo/GO_0005886 |
T5 | 1062-1075 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |